Cellectis (CLLS) Cash from Investing Activities (2015 - 2026)

Cellectis (CLLS) recorded quarterly Cash from Investing Activities of -$6.2 million in Q1 2026, down 127.46% quarter-over-quarter from $22.5 million in Q4 2025, and down 245.99% on a YoY basis from $4.2 million in Q1 2025.

Cellectis (CLLS) Cash from Investing Activities (2015 - 2026) Analysis & Trends

Cellectis' Cash from Investing Activities history runs 12 years deep, the most recent figure standing at -$6.2 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities fell 245.99% year-over-year to -$6.2 million; the TTM figure through Mar 2026 stood at -$39.9 million (up 58.7% YoY), while the FY2025 annual figure was -$29.5 million, up 71.32% from the prior year.
  • Cash from Investing Activities was -$6.2 million for Q1 2026 at Cellectis, down from $22.5 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $22.5 million in Q4 2025 to a low of -$106.4 million in Q2 2024.
  • Historically, Cash from Investing Activities has averaged -$9.2 million across 5 years, with a median of -$1.6 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities tumbled 8227.61% in 2023, then surged 7544.33% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$163000.0 in 2022, then sank by 8227.61% to -$13.6 million in 2023, then dropped by 22.74% to -$16.7 million in 2024, then soared by 234.75% to $22.5 million in 2025, then plunged by 127.46% to -$6.2 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$6.2 million (Q1 2026), $22.5 million (Q4 2025), and -$3.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Cellectis 17.40 Bn 17.21 Bn - -6.17 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.17 Mn
Mar 31, 2026 -6.17 Mn
Dec 31, 2025 22.45 Mn
Dec 31, 2025 22.45 Mn
Sep 30, 2025 -3.44 Mn
Sep 30, 2025 -3.44 Mn
Jun 30, 2025 -52.72 Mn
Jun 30, 2025 -52.72 Mn
Mar 31, 2025 4.22 Mn
Mar 31, 2025 4.22 Mn
Dec 31, 2024 -16.66 Mn
Dec 31, 2024 -16.66 Mn
Sep 30, 2024 22.33 Mn
Sep 30, 2024 22.33 Mn
Jun 30, 2024 -106.43 Mn
Jun 30, 2024 -106.43 Mn
Mar 31, 2024 -2.05 Mn
Mar 31, 2024 -2.05 Mn
Dec 31, 2023 -13.57 Mn
Dec 31, 2023 -13.57 Mn